SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-22-000567
Filing Date
2022-05-05
Accepted
2022-05-05 08:05:46
Documents
13
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 MIRUM PHARMACEUTICALS, INC. 8-K a52708955.htm   iXBRL 8-K 26263
2 EXHIBIT 99.1 a52708955ex99_1.htm EX-99.1 97063
  Complete submission text file 0001157523-22-000567.txt   274630

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mirm-20220505.xsd EX-101.SCH 3932
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20220505_lab.xml EX-101.LAB 23288
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20220505_pre.xml EX-101.PRE 16556
7 EXTRACTED XBRL INSTANCE DOCUMENT a52708955_htm.xml XML 4390
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 22894171
SIC: 2834 Pharmaceutical Preparations